Sciatica: What the Federal Pages Actually Say

MedlinePlus: “Sciatica is a symptom of a problem with the sciatic nerve, the largest nerve in the body.” Note the word symptom. “When you have sciatica, you have pain, weakness, numbness, or tingling.” “It can start in the lower back and extend down your leg to your calf, foot, or even your toes.” “It’s usually on only one side of your body.” The Medical Encyclopedia adds that the pain “Sciatica pain can vary widely. It may feel like a mild tingling, dull ache, or burning sensation.” and “The pain most often occurs on one side of the body.”

MedlinePlus names three causes: “A ruptured intervertebral disk”, “Narrowing of the spinal canal that puts pressure on the nerve, called spinal stenosis”, and “An injury such as a pelvic fracture.” And then the sentence that should govern every expectation anybody brings to a product in this category: “In many cases no cause can be found.” All three named causes are mechanical — something pressing on a nerve.

Two more sentences from MedlinePlus, and they are the two people search for most. “Sometimes sciatica goes away on its own.” And: “Treatment, if needed, depends on the cause of the problem. It may include exercises, medicines, and surgery.” Read those together and the shape of the thing is clear: the course varies, improvement without treatment happens, and what is done about it depends on what is causing it. Nothing in that sentence is a capsule, and nothing on this site says otherwise.

Four things in those quotations do most of the work on this whole site. Sciatica is described as a symptom, not as a disease in its own right — a symptom of a problem with the largest nerve in the body. All three named causes are mechanical: a ruptured disk, a narrowed spinal canal, a pelvic fracture. In many cases no cause is found at all. And what is done about it depends on what is causing it, which is why the federal sentence on treatment names exercises, medicines and surgery and stops there.

Here is the sentence that decides how to read the three trials on this panel, and it comes from NINDS: “Examples of conditions that cause neuropathic pain are diabetic neuropathy, shingles, and sciatica.” Diabetic neuropathy and sciatica sit in the same federal sentence, which is exactly why the comparison has to be made carefully rather than waved away. They are both neuropathic pain and they are not the same condition. MedlinePlus on the one this product is named after: “Sciatica occurs when there is pressure on or damage to the sciatic nerve.” Pressure on a nerve is mechanical. Diabetic polyneuropathy is metabolic nerve damage. No trial named anywhere on this site studied sciatica. That is not a claim that the ingredients are useless here: an ingredient studied in one nerve condition is not thereby useless in another. It is simply untested there, and untested is the accurate word.

Three rows on this panel carry named trials, and all three are smaller than the amounts those trials used. Put them in one place. Alpha lipoic acid: 400 mg printed against the 600 mg SYDNEY 2 called optimal — two-thirds — in diabetic distal symmetric polyneuropathy. Benfotiamine: 150 mg printed against the 300 mg lower arm of a placebo-controlled trial — half — in symmetrical distal diabetic polyneuropathy. Acetyl L-carnitine: 50 mg printed against 1,500 mg, the lowest of the three daily doses in the trials a Cochrane review examined — one thirtieth — in diabetic peripheral neuropathy. Two-thirds, one half, one thirtieth — and every one of the three was measured in diabetic neuropathy, which is not the condition on the front of the bottle.

Hold the two halves of that together, because either one alone is a distortion. The first half is that three ingredients here carry real, named, published trials, which is more than many products in this category can say, and the front of the bottle is entitled to the phrase “Clinically Studied Ingredients†” on the strength of it. The second half is that every one of those trials was carried out in diabetic neuropathy at a larger amount than this label prints, so the trials do not travel to sciatica and they do not travel down to these amounts. Untested is the accurate word, and it is not a synonym for useless.

In figures, printed against studied: alpha lipoic acid 400 mg against 600 mg, benfotiamine 150 mg against 300 mg, acetyl L-carnitine 50 mg against 1,500 mg. Four of the ten rows have a federal consumer fact sheet and 6 of the ten have none at all.

Of the ten ingredients on this panel, four have a NIH Office of Dietary Supplements consumer fact sheet — vitamin D3, vitamin B6, folate and vitamin B12 — and those four are the rows where a printed amount can be set against a recommended amount and an upper limit. Three carry a named clinical trial: alpha lipoic acid, benfotiamine and acetyl L-carnitine, all three in diabetic neuropathy. Three have no federal consumer amount for nerve pain at all: ashwagandha, broccoli and turmeric, each printed at 25 mg. For those three the honest report is that they are present, that the amount is small, and that nothing federal gives a figure to compare it with.

The four solid bars are the four rows where a reader can look up a recommended amount and an upper limit in an afternoon, and on this label both of those comparisons are to the label’s credit. The six hatched bars are not ingredients that failed a federal review. They are ingredients no federal consumer page gives an amount for in nerve pain, which means there is nothing published in either direction — nothing reassuring, nothing alarming, nothing.

FDA publishes a consumer page on health fraud scams, and the category it describes is the one this product is sold into: products marketed for a named condition, bought online, taken without telling a clinician. The page is linked in the sources at the foot of this page and it is worth ten minutes before any purchase in this category, including this one. Nothing on that page names this product, and this site does not suggest otherwise.

This desk did not run a database search on this product and does not publish one. No search, no date and no result was supplied, and a sentence of the form a search of such-and-such a list on such-and-such a date did not return this product is worth nothing unless the search was actually done. So there is no clearance claimed here, and no absence of a clearance implied either. If you want that check, FDA’s own pages are the place to run it and the sources below link them.

The actionable part is short and it has two addresses. A problem with the product — a reaction, a bottle that does not match its label, a claim that a supplement treats a disease — goes to FDA, through MedWatch or the consumer complaint system. A problem with the selling — a charge you did not authorise, a subscription you did not agree to, an advertisement that was not true — goes to the Federal Trade Commission at reportfraud.ftc.gov. Both are free, both take a few minutes, and both work better with the order ID and a screenshot in front of you.

Nothing in those three paragraphs is a verdict on the bottle this site is about. They name a federal consumer page, state plainly that no database search was run by this desk and that none is published, and end on two addresses that work. In that order it is information. In any other order it would be an insinuation, and this site does not publish one.